Mitelman, Serge A.
Bralet, Marie-Cecile
Haznedar, M. Mehmet
Hollander, Eric
Shihabuddin, Lina
Hazlett, Erin A.
Buchsbaum, Monte S.
Funding for this research was provided by:
National Institute of Mental Health (MH 077146, P50 MH 66392-01, MH 56489)
National Alliance for Research on Schizophrenia and Depression (Young Investigator Award)
Article History
First Online: 23 November 2016
Compliance and ethical standards
: All procedures performed in this study were in accordance with the ethical standards of the Mount Sinai institutional research committee, as well as with the 1964 Helsinki declaration and its later amendments. The project was approved by the institutional review board of The Icahn School of Medicine at Mount Sinai.
: This work was partly supported by NARSAD Young Investigator Award and NIMH MH 077146 grant to Serge A. Mitelman and by NIMH grants P50 MH 66392–01, MH 60023, and MH 56489 to Monte S. Buchsbaum.
: Author Serge A. Mitelman declares that he has no conflict of interest to report.Author Marie-Cecile Bralet declares that she has no conflict of interest to report.Author M. Mehmet Haznedar declares that he has no conflict of interest to report.Author Eric Hollander has received consultation fees from Transceit, Neuropharm, and Nastech.Author Lina Shihabuddin declares that she has no conflict of interest to report.Author Erin A. Hazlett declares that she has no conflict of interest to report.Author Monte S. Buchsbaum declares that he has no conflict of interest to report.
: Informed consent was obtained from all individual participants in the study.